NASDAQ: QNTM
Quantum Biopharma Ltd Stock Ownership - Who owns Quantum Biopharma?

Insider buying vs selling

Have Quantum Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when QNTM insiders and whales buy or sell their stock.

QNTM Shareholders

What type of owners hold Quantum Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Advis50.00%204$746.64Institution
Advisorshares Investments LLC0.00%203$742.98Institution
Jane Street Group LLC0.00%48$175.68Institution
Janstr0.00%48$175.68Institution
Platform Technology Partners0.00%41$150.06Institution
Platec0.00%41$150.06Institution
Ubsgro0.00%33$120.78Institution
Ubs Group Ag0.00%33$120.78Institution
Stewar0.00%28$102.48Institution
Steward Partners Investment Advisory LLC0.00%27$98.82Institution

1 of 3

QNTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNTM0.01%0.00%
RNAZ0.00%22.26%
NXTC0.01%99.99%Net BuyingNet Buying
EVAX0.00%5.19%
KYNB0.01%99.99%Net BuyingNet Selling

Quantum Biopharma Stock Ownership FAQ

Who owns Quantum Biopharma?

Quantum Biopharma (NASDAQ: QNTM) is owned by 0.01% institutional shareholders, 0.00% Quantum Biopharma insiders, and 99.99% retail investors. Advis5 is the largest individual Quantum Biopharma shareholder, owning 204.00 shares representing 0.00% of the company. Advis5's Quantum Biopharma shares are currently valued at $746.64.

If you're new to stock investing, here's how to buy Quantum Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.